Clinical Trials on Platinum-Refractory Ovarian Carcinoma in Korea, Democratic People's Republic of
Total 104 results
-
Seoul National University HospitalPharos iBio Co., Ltd.RecruitingPlatinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-refractory Ovarian CarcinomaKorea, Republic of
-
Yonsei UniversitySamsung Medical Center; AstraZeneca; Seoul National University Hospital; Korean... and other collaboratorsRecruitingPlatinum-resistant Recurrent Ovarian CancerKorea, Republic of
-
Yonsei UniversityEnrolling by invitationPlatinum-sensitive Recurrent BRCA Wild Type Ovarian CancerKorea, Republic of
-
Yonsei UniversityTakedaRecruitingPlatinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP InhibitorKorea, Republic of
-
Yonsei UniversityCanariaBio Inc.RecruitingPARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum RetreatmentKorea, Republic of
-
Yonsei UniversityCompletedOvarian Cancer (Epithelial)Korea, Republic of
-
Yonsei UniversityRecruitingRecurrent Ovarian CancerKorea, Republic of
-
Yonsei UniversityCompletedAdvanced-stage Ovarian CancerKorea, Republic of
-
Asan Medical CenterSanofiCompletedAdvanced Ovarian CancerKorea, Republic of
-
Yonsei UniversityCompleted
-
Asan Medical CenterUnknownOvarian CancerKorea, Republic of
-
Asan Medical CenterUnknownEpithelial Ovarian CancerKorea, Republic of
-
Pharmicell Co., Ltd.TerminatedOvarian CancerKorea, Republic of
-
Yonsei UniversityCompletedOvarian CancerKorea, Republic of
-
Yonsei UniversityRecruitingOvarian CancerKorea, Republic of
-
Yonsei UniversityRecruitingRecurrent Epithelial Ovarian CancerKorea, Republic of
-
Ajou University School of MedicineUnknownOvarian CancerKorea, Republic of
-
National Cancer Center, KoreaAjou UniversityCompletedEpithelial Ovarian CancerKorea, Republic of
-
Yonsei UniversityNational Cancer Center, Korea; Samsung Medical Center; AstraZeneca; Seoul National... and other collaboratorsUnknownOvarian Cancer Stage IIIC | Ovarian Cancer Stage IVKorea, Republic of
-
Konkuk University Medical CenterNational Cancer Center, Korea; Samsung Medical Center; Asan Medical Center; Seoul... and other collaboratorsCompletedOvarian CarcinomaKorea, Republic of
-
Asan Medical CenterNational Cancer Center, Korea; Samsung Medical Center; Seoul St. Mary's Hospital and other collaboratorsCompletedEpithelial Ovarian CancerKorea, Republic of
-
Seoul National University HospitalRecruitingFallopian Tube Cancer | Peritoneal Cancer | Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IVKorea, Republic of
-
Seoul National University HospitalUnknownFallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Epithelial Ovarian CarcinomaKorea, Republic of
-
Samsung Medical CenterMerck Sharp & Dohme LLCCompletedOvarian Cancer | Chemotherapy-Induced Nausea and VomitingKorea, Republic of
-
Seoul National University HospitalSamyang Biopharmaceuticals CorporationCompletedOvarian CancerKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedEpithelial Ovarian CancerKorea, Republic of
-
Yonsei UniversityRecruitingFallopian Tube Cancer | Primary Peritoneal Cancer | Mucinous Ovarian CancerKorea, Republic of
-
Korea University Guro HospitalYonsei University; Boryung Pharmaceutical Co., Ltd; Chong Kun Dang Pharmaceutical...RecruitingOvarian Cancer | Drug Related Neoplasm/CancerKorea, Republic of
-
The Catholic University of KoreaKorean Cancer Study GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerKorea, Republic of
-
Seoul National University HospitalBoryung Pharmaceutical Co., LtdActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Recurrent Ovarian Carcinoma | Chemotherapy-induced Peripheral Neuropathy | Primary Peritoneal CarcinomaKorea, Republic of
-
National Cancer Center, KoreaRecruitingOvarian CancerKorea, Republic of
-
Seoul National University HospitalUnknownHigh Grade Serous Carcinoma | Ovarian Neoplasm EpithelialKorea, Republic of
-
CanariaBio Inc.Korean Cancer Study GroupRecruitingOvarian Cancer Stage IV | Ovarian Cancer Stage III | Ovarian Cancer by FIGO StageKorea, Republic of
-
Seoul National University HospitalRecruitingQuality of Life | Ovarian Cancer | Low Anterior Resection SyndromeKorea, Republic of
-
National Cancer Center, KoreaRecruitingEpithelial Ovarian CancerKorea, Republic of
-
Samyang Biopharmaceuticals CorporationCompleted
-
National Cancer Center, KoreaCompletedOvarian CancerKorea, Republic of
-
Seoul National University HospitalCompletedLymph Node Metastases | Ovarian Cancer Stage IVKorea, Republic of
-
Shanghai Gynecologic Oncology GroupRecruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaKorea, Republic of, China
-
AstraZenecaMyriad Genetic Laboratories, Inc.WithdrawnPlatinum Sensitive Relapsed Ovarian CancerUnited States, Korea, Republic of, Peru, United Kingdom, Philippines
-
AstraZenecaCompletedStomach Neoplasms | Small Cell Lung Carcinoma | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Triple Negative Breast Neoplasms | Esophageal Squamous Cell Carcinoma | Carcinoma, Pancreatic Ductal | Carcinoma, Squamous Cell of Head and Neck | Esophagogastric Junction NeoplasmsKorea, Republic of, Japan
-
Millennium Pharmaceuticals, Inc.TerminatedSmall Cell Lung Cancer | Ovarian Cancer | Advanced Solid TumorsJapan, Korea, Republic of
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain
-
Sutro Biopharma, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups... and other collaboratorsRecruitingOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Australia, Korea, Republic of, Israel, Singapore, Canada
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Italy, Spain, Belgium, Poland, Canada, Korea, Republic of, Brazil, Czechia, Hungary, Israel, Argentina, Mexico
-
SN BioScienceNot yet recruitingBreast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Small-cell Lung Cancer | Pancreas CancerKorea, Republic of
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
Eisai Inc.PharmaBio Development Inc.CompletedPlatinum-Resistant Squamous Cell Carcinoma of the Head and NeckUnited States, Korea, Republic of, Ukraine, United Kingdom
-
AstraZenecaRTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)CompletedPlatinum-sensitive Recurrent Serous Ovarian CancerFrance, Italy, Korea, Republic of, Spain, United Kingdom, Germany, Belgium, Israel, Portugal, Netherlands, Switzerland, Canada, Australia
-
Mural Oncology, IncMerck Sharp & Dohme LLCRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Taiwan, Canada, Israel, France, United Kingdom, Germany, Belgium, Czechia, Singapore, Australia, Austria, Italy